Organigram Signs Three Year Supply Agreement with Avida Medical in UK
-
Over a three-year period,
expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement.Organigram -
Avida Medical to become Organigram’s second international medical cannabis customer in the
UK . -
Organigram to grant Avida Medical strain exclusivity in theUK for three strains. -
To date,
Organigram has established international supply agreements with a total of seven medical cannabis customers inAustralia ,Germany ,Israel , and theUK , aligned to its strategy to extend its reach beyondCanada into global markets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240528337587/en/
Organigram Signs Three Year Supply Agreement with Avida Medical in
Subject to the terms of the Agreement, the Company expects to supply 1,700 kilograms of high-quality, indoor-grown dried cannabis flower to Avida Medical in the
"We are pleased to partner with Avida Medical in the
“Our agreement with
“This is a hugely positive collaboration for Avida Medical and brings us a step closer to becoming one of the pre-eminent manufacturers of medicinal cannabis products here in the UK,” he added.
About
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of
Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include termination of the Supply Agreement by either party prior to the three year term, customer demand and buying patterns and factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the
Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528337587/en/
For Media enquiries:
SVP of Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
F
or Business enquiries:
VP of International Business Development
andrew.miller@organigram.ca
F
or Investor Relations enquiries:
Director of Investor Relations
investors@organigram.ca
Source: